Literature DB >> 19399597

Post-translational modifications of ATP synthase in the heart: biology and function.

Lesley A Kane1, Jennifer E Van Eyk.   

Abstract

The ATP synthase complex is a critical enzyme in the energetic pathways of cells because it is the enzyme complex that produces the majority of cellular ATP. It has been shown to be involved in several cardiac phenotypes including heart failure and preconditioning, a cellular protective mechanism. Understanding the regulation of this enzyme is important in understanding the mechanisms behind these important phenomena. Recently there have been several post-translational modifications (PTM) reported for various subunits of this enzyme complex, opening up the possibility of differential regulation by these PTMs. Here we discuss the known PTMs in the heart and other mammalian tissues and their implication to function and regulation of the ATP synthase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399597      PMCID: PMC2905846          DOI: 10.1007/s10863-009-9218-6

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  40 in total

1.  Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins.

Authors:  Steven W Taylor; Eoin Fahy; James Murray; Roderick A Capaldi; Soumitra S Ghosh
Journal:  J Biol Chem       Date:  2003-04-04       Impact factor: 5.157

Review 2.  Functions of site-specific histone acetylation and deacetylation.

Authors:  Mona D Shahbazian; Michael Grunstein
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

3.  Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol.

Authors:  Keith Vosseller; Kirk C Hansen; Robert J Chalkley; Jonathan C Trinidad; Lance Wells; Gerald W Hart; Alma L Burlingame
Journal:  Proteomics       Date:  2005-02       Impact factor: 3.984

4.  Proteome analysis reveals phosphorylation of ATP synthase beta -subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes.

Authors:  Kurt Højlund; Krzysztof Wrzesinski; Peter Mose Larsen; Stephen J Fey; Peter Roepstorff; Aase Handberg; Flemming Dela; Jørgen Vinten; James G McCormack; Christine Reynet; Henning Beck-Nielsen
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

Review 5.  Regulatory mechanisms of proton-translocating F(O)F (1)-ATP synthase.

Authors:  Boris A Feniouk; Masasuke Yoshida
Journal:  Results Probl Cell Differ       Date:  2008

6.  Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity.

Authors:  Gary J Grover; Karnail S Atwal; Paul G Sleph; Feng-Li Wang; Hossain Monshizadegan; Thomas Monticello; David W Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-10       Impact factor: 4.733

Review 7.  Transport ATPases into the year 2008: a brief overview related to types, structures, functions and roles in health and disease.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

Review 8.  Chemical mechanisms of histone lysine and arginine modifications.

Authors:  Brian C Smith; John M Denu
Journal:  Biochim Biophys Acta       Date:  2008-06-14

9.  Lysine 43 is trimethylated in subunit C from bovine mitochondrial ATP synthase and in storage bodies associated with batten disease.

Authors:  Ruming Chen; Ian M Fearnley; David N Palmer; John E Walker
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

Review 10.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

View more
  20 in total

Review 1.  Nitrite as a mediator of ischemic preconditioning and cytoprotection.

Authors:  Daniel Murillo; Christelle Kamga; Li Mo; Sruti Shiva
Journal:  Nitric Oxide       Date:  2011-01-26       Impact factor: 4.427

2.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

Review 3.  Regulation of mitochondrial ATP synthase in cardiac pathophysiology.

Authors:  Qinqiang Long; Kevin Yang; Qinglin Yang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

Review 4.  Role of mitochondrial Ca2+ in the regulation of cellular energetics.

Authors:  Brian Glancy; Robert S Balaban
Journal:  Biochemistry       Date:  2012-03-29       Impact factor: 3.162

Review 5.  Proteomic responses of skeletal and cardiac muscle to exercise.

Authors:  Jatin G Burniston; Eric P Hoffman
Journal:  Expert Rev Proteomics       Date:  2011-06       Impact factor: 3.940

Review 6.  Mitochondria from anoxia-tolerant animals reveal common strategies to survive without oxygen.

Authors:  Gina L J Galli; Jeffrey G Richards
Journal:  J Comp Physiol B       Date:  2014-02-07       Impact factor: 2.200

Review 7.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

Review 8.  Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system.

Authors:  Heaseung S Chung; Sheng-Bing Wang; Vidya Venkatraman; Christopher I Murray; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 9.  Redox regulation of mitochondrial ATP synthase.

Authors:  Sheng-Bing Wang; Christopher I Murray; Heaseung S Chung; Jennifer E Van Eyk
Journal:  Trends Cardiovasc Med       Date:  2013-01       Impact factor: 6.677

10.  Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.

Authors:  Trisha J Grevengoed; Daniel E Cooper; Pamela A Young; Jessica M Ellis; Rosalind A Coleman
Journal:  FASEB J       Date:  2015-07-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.